USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Sep 21, 2017
app pub date -
Dec 29, 2016
filing date -
Dec 29, 2016
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Methods are provided for treating a hematologic cancer comprising administering an anticancer agent to a subject identified as having an increased mobilization of a subpopulation of lymphocytes from a malignancy following administration of an irreversible Btk inhibitor. Methods also are provided for identification of subjects for treatment and the analysis of cells mobilized from a hematologic malignancy following administration of an irreversible Btk inhibitor.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully